Cell & Gene Exchange, May 2017: BrainStorm Cell Therapeutics - Chaim Lebovits, CEO, Brainstorm Cell Therapeutics Inc 00:00:00

Share On Facebook Share On Twitter

Chaim Lebovits joined BrainStorm in July 2007 as President and has served as Chief Executive Officer since September 2015. He has been instrumental in shaping development of the NurOwn® technology platform from early preclinical stages to the current phase 3 clinical program in the United States.

Recent Videos